Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,436 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Preoperative doxorubicin instillation in recurrent superficial bladder cancer.
Kubota Y, Noguchi S, Shuin T, Moriyama M, Hosaka M, Satomi Y, Furuhata A, Kondo I, Sakuramoto T, Yao M, et al. Kubota Y, et al. Among authors: moriyama m. Cancer Chemother Pharmacol. 1987;20 Suppl:S56-9. doi: 10.1007/BF00262487. Cancer Chemother Pharmacol. 1987. PMID: 3664944 Clinical Trial.
[Phase II study of 5-FU tablet in bladder tumor].
Nagamoto A, Kubota Y, Shuin T, Kondo I, Moriyama M, Satomi Y, Fukushima S, Fukuoka H, Ishizuka E, Furuhata A, et al. Nagamoto A, et al. Among authors: moriyama m. Gan To Kagaku Ryoho. 1989 Apr;16(4 Pt 1):845-50. Gan To Kagaku Ryoho. 1989. PMID: 2653223 Clinical Trial. Japanese.
A phase II study of prophylactic intravesical chemotherapy with 4'-epirubicin in recurrent superficial bladder cancer: comparison of 4'-epirubicin and adriamycin.
Shuin T, Kubota Y, Noguchi S, Hosaka M, Miura T, Kondo I, Fukushima S, Ishizuka E, Furuhata A, Moriyama M, et al. Shuin T, et al. Among authors: moriyama m. Cancer Chemother Pharmacol. 1994;35 Suppl:S52-6. doi: 10.1007/BF00686920. Cancer Chemother Pharmacol. 1994. PMID: 7994787 Clinical Trial.
[5'-DFUR chemoprophylaxis in superficial bladder cancer. Kanagawa Urology 5'-DFUR Study Group].
Kubota Y, Noguchi S, Masuda M, Hosaka M, Noguchi K, Sasaki K, Miura T, Ikeda I, Kondo I, Senga Y, Moriyama M, Fukushima S, Ebato T, Fukuda M, Kitami K, Fukuoka H, Sato K, Hirokawa M, Chiba K, Kanno H, Miyai K. Kubota Y, et al. Among authors: moriyama m. Hinyokika Kiyo. 2000 Aug;46(8):525-30. Hinyokika Kiyo. 2000. PMID: 11019370 Free article. Clinical Trial. Japanese.
[Phase II study of 5'-DFUR (Furtulon) capsule for bladder cancer].
Kubota Y, Miura T, Shuin T, Kinoshita Y, Hosaka M, Kondo I, Moriyama M, Fukushima S, Fukuoka H, Miyai K, et al. Kubota Y, et al. Among authors: moriyama m. Gan To Kagaku Ryoho. 1991 Oct;18(13):2301-6. Gan To Kagaku Ryoho. 1991. PMID: 1834023 Japanese.
[Bladder cancer in patients under fifty years of age].
Miura T, Kubota Y, Ishibashi Y, Sakuramoto T, Noguchi S, Moriyama M, Shuin T, Fukushima S, Satomi Y. Miura T, et al. Among authors: moriyama m. Hinyokika Kiyo. 1986 Feb;32(2):189-93. Hinyokika Kiyo. 1986. PMID: 3728225 Free article. Japanese.
1,436 results